| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT07136701 Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs… |
Recruitment opened |
| 2026-08-11 | NCT07543263 An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic… |
Recruitment opened |
| 2026-08-11 | NCT07488299 The Effect of Proton Pump Inhibitors(PPIs) on Endoscopic Treatment of Walled-off Necrosis… |
Recruitment opened |
| 2026-08-02 | NCT06531226 Difficult Colonoscopy and Personality Traits |
overall status: Not Yet Recruiting → Unknown |
| 2026-07-29 | NCT07111273 DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive… |
Recruitment opened |
| 2026-07-29 | NCT07111572 Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-12 | NCT07761455 Prophylactic IABP in Delayed-Presentation Anterior STEMI | Not Yet Recruiting | |
| 2026-08-11 | NCT07757906 Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in… | Not Yet Recruiting | |
| 2026-08-11 | NCT07757919 Efficacy and Safety of 14-Day Vonoprazan-Minocycline Dual Therapy for Helicobacter Pylori… | Phase 4 | Not Yet Recruiting |
| 2026-08-06 | NCT07750938 Optimizing H. Pylori Eradication Regimen Under Intensified Acid Suppression | Phase 4 | Not Yet Recruiting |
| 2026-08-03 | NCT07742410 The Fecal Immunoassay Occult Blood Test Combined With Calprotectin Sequential Linkage… | Not Yet Recruiting | |
| 2026-07-23 | NCT07722910 Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05626348 | The Clinical Efficacy of Immunomodulators in RA Patients | Arthritis, Rheumatoid | Recruiting |
| NCT06092736 | Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) | Microvascular Angina | Recruiting |
| NCT06699420 | Qishenyiqi Dripping Pill for Coronary Microvascular Disease | Coronary Microvascular Disease | Recruiting |
| NCT04728516 | The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients | Acute Coronary Syndrome | Recruiting |
| NCT06699407 | Qishenyiqi for Ventricular Remodeling After Myocardial Infarction | Chronic Stable Heart Failure | Not Yet Recruiting |
| NCT06727890 | Compound Danshen Dripping Pill for Diabetic Microvascular Angina | Diabetic Microvascular Angina | Not Yet Recruiting |
| NCT07750938 | Optimizing H. Pylori Eradication Regimen Under Intensified Acid Suppression | HELICOBACTER PYLORI INFECTIONS | Not Yet Recruiting |
| NCT07757919 | Efficacy and Safety of 14-Day Vonoprazan-Minocycline Dual Therapy for Helicobacter Pylori… | HELICOBACTER PYLORI INFECTIONS | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06678685 | Spironolactone Improved Children With Gene Mutations Related to NCOR | NCOR Gene Mutations | Recruiting |
| Phase 2 | |||
| NCT06242067 | Second-line Treatment of Metastatic Colorectal Cancer | Metastatic Colorectal Cancer | Recruiting |
| NCT06454578 | Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence… | Carcinoma, Hepatocellular | Recruiting |
| NCT06735326 | Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer | Ovarian Cancer | Recruiting |
| NCT06730373 | First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) | HER2-positive Gastric Cancer | Recruiting |
| NCT07264803 | A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug… | Solid Tumor Malignancies | Recruiting |
| NCT07537348 | Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and… | Advanced Gastric Cancer | Recruiting |
| NCT07537361 | Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and… | Gastric Cancer | Recruiting |
| NCT06932068 | Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1… | HER2 Negative | Recruiting |
| NCT07089199 | Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell… | NSCLC | Recruiting |
| NCT06500247 | Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced… | The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer | Not Yet Recruiting |
| NCT06239532 | HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable… | Intrahepatic Cholangiocarcinoma | Active, Not Recruiting |
| NCT05586061 | First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer | HER2-positive Gastric Cancer | Active, Not Recruiting |
| NCT06880926 | Antarctic Krill Oil for Knee Osteoarthritis Pain | Osteoarthritis (OA) of the Knee | Not Yet Recruiting |
| NCT07156682 | QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer | Colon Cancer | Not Yet Recruiting |
| NCT07172217 | The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing… | Recurrent Cervical Cancer | Not Yet Recruiting |
| NCT07201675 | Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment | Muscle Invasive Bladder Cancer (MIBC) | Not Yet Recruiting |